Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

Int J Chron Obstruct Pulmon Dis. 2015 Jul 30:10:1513. doi: 10.2147/COPD.S82829. eCollection 2015.
No abstract available

Publication types

  • Published Erratum